U.S. Markets close in 2 hrs 53 mins

Alimera Sciences, Inc. (ALIM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.37+0.02 (+1.48%)
As of 1:07PM EDT. Market open.
People also watch
PSDVACRXANTHAPRIEVOK
Full screen
Previous Close1.35
Open1.36
Bid1.36 x 10700
Ask1.37 x 200
Day's Range1.36 - 1.38
52 Week Range1.03 - 1.72
Volume56,220
Avg. Volume253,221
Market Cap94.6M
Beta2.81
PE Ratio (TTM)-3.49
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube18 days ago

    ETFs with exposure to Alimera Sciences, Inc. : September 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Alimera Sciences, Inc. Here are 5 ETFs with the largest exposure to ALIM-US. Comparing the performance and risk of Alimera Sciences, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017
    Capital Cube19 days ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017

    Categories: Yahoo FinanceGet free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., Eleven Biotherapeutics, Inc., Aerie Pharmaceuticals, Inc., Mateon Therapeutics, Inc., Regeneron Pharmaceuticals, Inc. and Insmed Incorporated (OPHT-US, EBIO-US, AERI-US, MATN-US, REGN-US and INSM-US) ... Read more (Read more...)

  • Thomson Reuters StreetEventslast month

    Edited Transcript of ALIM earnings conference call or presentation 3-Aug-17 1:00pm GMT

    Q2 2017 Alimera Sciences Inc Earnings Call